Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

Sinclair non-exec takes more shares

Tue, 03rd May 2011 17:26
Jean-Charles Tschudin, a non-executive director at the skin care products supplier Sinclair Pharma, has added to his holding in the company with the purchase of 56,000 shares at 36p a time.He now has 967,117 shares, which is about 0.4% of the company.Top Director BuysQatar Investment Fund (QIF) Director name: Mr David von SimsonAmount purchased: 75,000 @ $0.93 Value: $69,750Sinclair Pharma (SPH) Director name: Mr Jean-Charles TschudinAmount purchased: 56,000 @ 36.00p Value: £20,160Witan Inv Trust (WTAN) Director name: Mr Robert W BoyleAmount purchased: 2,024 @ 525.00p Value: £10,626Top Director SellsTitan Europe (TSW) Director name: Mr Erwin Henryk BilligAmount sold: 40,000 @ 109.00p Value: £43,600

Related News

Witan reports solid first-half return ahead of proposed Alliance merger
13 Aug 2024

Witan reports solid first-half return ahead of proposed Alliance merger

(Sharecast News) - Witan Investment Trust reported a strong first-half financial performance on Tuesday, with a significant increase in net asset valu...

Sinclair Pharma News

UPDATE 1-Sinclair IS Pharma says evaluating options including sale
25 Nov 2014

UPDATE 1-Sinclair IS Pharma says evaluating options including sale

(Adds details, share movement) Nov 25 (Reuters) - Diversified pharmaceutical company Sinclair IS Pharma said it was evaluating options including a pos...

Sinclair IS Pharma says evaluating options including sale
25 Nov 2014

Sinclair IS Pharma says evaluating options including sale

Nov 25 (Reuters) - Diversified pharmaceutical company Sinclair IS Pharma said it was evaluating options including a possible sale. The company, which ...

Tuesday broker round-up UPDATE
7 Oct 2014

Tuesday broker round-up UPDATE

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 15...

CORRECTED-Sinclair IS Pharma full-year revenue jumps as acquisitions pay off
18 Sep 2014

CORRECTED-Sinclair IS Pharma full-year revenue jumps as acquisitions pay off

(Corrects Reuters Instrument Code in first paragraph to SPH.L from SHP.L) Sept 18 (Reuters) - Sinclair IS Pharma Plc reported a 15 percent rise in rev...